Posts Tagged ‘hopkins’


In STEM CELLS IN THE NEWS on May 28, 2014 at 11:42 am

​Let’s be careful out there guys.  While every word in the below article MAY be true, there is no association whatsoever between this list and John Hopkins.  The first clue is that there are no references, no footnotes, no backlinks.  Then you go to Hopkins and see they have called it a hoax – http://m.hopkinsmedicine.org/kimmel_cancer_center/news_events/featured/cancer_update_email_it_is_a_hoax.html and finally, Snopes shoots it down –

What’s very frustrating to me is that the dissemination of unreferenced data damages the hard work of “non-traditional” healers and healing techniques and makes anything with “alternative”, “holistic”, “natural”, etc seem to be a scam via guilt by association.  Is there truth in the above? Maybe, but finding it out just got set back significantly as the baby gets thrown out with the bathwater.

Science is a tool.  It’s neither good nor evil.  And there are many, many studies showing huge benefits from  “alternative”, “holistic”, “natural”, therapies.  Science is also slow and there typically needs to be a huge $ sign and a mass producible and patentable pill at the end of the road (7-10 yrs and $250 million) for a study/trial to happen.  These are some of the reasons stem cell treatments are taking so long to get into mainstream Western medicine.   https://repairstemcell.wordpress.com/why-no-stem-cells-in-the-us Part1/

Techniques described as “alternative”, “holistic” and “natural” are essentially working with a huge handicap on many levels.  I am all for ‘changing the system’ as it is fundamentally broken. https://repairstemcell.wordpress.com/why-are-there-still-no-stem-cells-in-the-us Part2/  but this is not the way.  Ultimately, sharing this info without references damages those looking for real healing options.



Big Hospital Finally telling the truth about Cancer, Johns Hopkins

from Johns Hopkins


1. Every person has cancer cells in the body. These cancer cells do not show up in the standard tests until they have multiplied to a few billion. When doctors tell cancer patients that there are no more cancer cells in their bodies after treatment, it just means the tests are unable to detect the cancer cells because they have not reached the detectable size.

2. Cancer cells occur between 6 to more than 10 times in a person’s lifetime.

3. When the person’s immune system is strong the cancer cells will be destroyed and prevented from multiplying and forming tumors.

4. When a person has cancer it indicates the person has multiple nutritional deficiencies. These could be due to genetic, environmental, food and lifestyle factors.

5. To overcome the multiple nutritional deficiencies, changing diet and including supplements will strengthen the immune system.

6. Chemotherapy involves poisoning the rapidly-growing cancer cells and also destroys rapidly-growing healthy cells in the bone marrow, gastro-intestinal tract etc, and can cause organ damage, like liver, kidneys, heart, lungs etc.

7. Radiation while destroying cancer cells also burns, scars and damages healthy cells, tissues and organs.

8. Initial treatment with chemotherapy and radiation will often reduce tumor size. However prolonged use of chemotherapy and radiation do not result in more tumor destruction.

9. When the body has too much toxic burden from chemotherapy and radiation the immune system is either compromised or destroyed, hence the person can succumb to various kinds of infections and complications.

10. Chemotherapy and radiation can cause cancer cells to mutate and become resistant and difficult to destroy. Surgery can also cause cancer cells to spread to other sites.

11. An effective way to battle cancer is to STARVE the cancer cells by not feeding it with foods it needs to multiple.

What cancer cells feed on:

a. Sugar is a cancer-feeder. By cutting off sugar it cuts off one important food supply to the cancer cells. Note:Sugar substitutes like NutraSweet, Equal, Spoonful, etc are made with Aspartame and it is harmful. A better natural substitute would be Manuka honey or molasses but only in very small amounts. Table salt has a chemical added to make it white in colour. Better alternative is Bragg’s aminos or sea salt.

b. Milk causes the body to produce mucus, especially in the gastro-intestinal tract. Cancer feeds on mucus. By cutting off milk and substituting with unsweetened soy milk, cancer cells will starved.

c. Cancer cells thrive in an acid environment. A meat-based diet is acidic and it is best to eat fish, and a little chicken rather than beef or pork. Meat also contains livestock antibiotics, growth hormones and parasites, which are all harmful, especially to people with cancer.

d. A diet made of 80% fresh vegetables and juice, whole grains, seeds, nuts and a little fruits help put the body into an alkaline environment. About 20% can be from cooked food including beans. Fresh vegetable juices provide live enzymes that are easily absorbed and reach down to cellular levels within 15 minutes t o nourish and enhance growth of healthy cells.

To obtain live enzymes for building healthy cells try and drink fresh vegetable juice (most vegetables including bean sprouts) and eat some raw vegetables 2 or 3 times a day. Enzymes are destroyed at temperatures of 104 degrees F (40 degrees C).

e. Avoid coffee, tea, and chocolate, which have high caffeine. Green tea is a better alternative and has cancer-fighting properties. Water–best to drink purified water, or filtered, to avoid known toxins and heavy metals in tap water. Distilled water is acidic, avoid it.

12. Meat protein is difficult to digest and requires a lot of digestive enzymes. Undigested meat remaining in the intestines will become putrified and leads to more toxic buildup.

13. Cancer cell walls have a tough protein covering. By refraining from or eating less meat it frees more enzymes to attack the protein walls of cancer cells and allows the body’s killer cells to destroy the cancer cells.

14. Some supplements build up the immune system (IP6, Flor-ssence, Essiac, anti-oxidants, vitamins, minerals, EFAs etc.) to enable the body’s own killer cells to destroy cancer cells. Other supplements like vitamin E are known to cause apoptosis, or programmed cell death, the body’s normal method of disposing of damaged, unwanted, or unneeded cells.

15. Cancer is a disease of the mind, body, and spirit. A proactive and positive spirit will help the cancer warrior be a survivor.

Anger, unforgiving and bitterness put the body into a stressful and acidic environment. Learn to have a loving and forgiving spirit. Learn to relax and enjoy life.

16. Cancer cells cannot thrive in an oxygenated environment. Exercising daily, and deep breathing help to get more oxygen down to the cellular level. Oxygen therapy is another means employed to destroy cancer cells.

Patient’s own stem cells help heal heart, early research shows – CNN.com

In CATCH UP!, VICTORIES & SUCCESS STORIES on February 14, 2012 at 3:27 am

7 long years.

It has taken 7 years for the US medical system to CATCH UP to the rest of the world.  This article, though pro-adult stem cell, uses the same tired, B.S. lines like:

“This is the first instance of therapeutic regeneration”

This article blatantly ignores the thousands of of studies, trials and patients successfully treated over the last 7 years.  Sadly, we won’t see stem cell treatments readily, commonly and commercially available in the US for a long time. 

Many people will offer comments on these developments…

The uninformed will say: “first time ever!”

The optimists will say: “better late than never”

The realists will say: “10 years before US patients will have access to these treatments”

The families of those who have died over the past 7 years will say: “if only the US woke up sooner”


Stem cell treatments are available NOW outside of the United States at some of the most modern and advanced hospitals and clinics in the world.  Maybe, just maybe, the families of those who WILL die from heart disease over the NEXT 10 years will say:

“NOW is the time to go where they have been treating heart disease with stem cells for over half a decade”

For info on CURRENTLY AVAILABLE stem cell treatments for heart disease:


For more info and the HISTORY of stem cells for heart disease :


Patient's own stem cells help heal heart, early research shows

Patient’s own stem cells help heal heart, early research shows

A patient’s own heart cells can be used to regrow new heart tissue and help undo damage caused by a heart attack, according to early research published on Monday.

Scientists at Cedars-Sinai Medical Center in Los Angeles and Johns Hopkins University in Baltimore were able to treat 17 heart attack patients with cells grown from their own heart tissue and not only show the procedure was safe, but also that the cells can help reduce scarring and even cause new heart muscle to grow.

When a person suffers a heart attack, he or she is often left with huge areas of scarring in the heart. Scarred heart muscle doesn’t pump blood as well as it used to, putting stress on other parts of the heart to make up for the deficit. The damaged area also doesn’t conduct electric current as well, leading to an abnormal heart rhythm, which can cause more problems. Heart attack patients often go on to develop heart failure.

“This is the first instance of therapeutic regeneration,” says Dr. Eduardo Marbán, director of the Cedars-Sinai Heart Institute. He says while nature abounds with examples of spontaneous regeneration of limbs or tissues – like a salamander’s new tail or a human liver regrowing to full size if partially damaged – doctors have not been able to help patients regrow heart tissue. This could change in the future if larger clinical trials and longer patient outcomes confirm the results of this early research published Monday in the journal The Lancet.  Marbán and his colleagues first presented this research at an American Heart Association conference in November…

Patient’s own stem cells help heal heart, early research shows – – CNN.com Blogs.


In ALL ARTICLES on November 15, 2011 at 1:23 pm
The king is dead, long live the king!
Embryonic stem cells are dead, long live Adult stem cells!

In early 2009 I wrote an article called “SCREW THE EMBRYOS, THEY’RE IRRELEVANT!


“…since few people can afford to travel outside the country for adult stem cell treatments, ESC-crazed America, the Bangladesh of stem cells, with its focus on “treatment useless” research, and 4-8 years behind the rest of the world (in 2009) on available adult stem cell treatments, has become exactly that, a death row prison cell for those suffering from so-called untreatable diseases.”

In “SCREW THE EMBRYOS”, I explained why Embryonic stem cells will not treat humans for decades.  I explained how embryonic research has been 100% fruitless (in regard to generating treatments) for well-funded and government supported scientists around the world for the last 13 years. I explained how Adult stem cells have been treating patients outside the USA for years and I shared what a tragic, terrible waste of life it is that Americans don’t know there are safe and effective treatment options for over 100 incurable diseases.

With Embryonic stem cell treatment research now an obvious waste of time, money and resources, where should the desperate patient with chronic or incurable disease turn?  Adult Stem Cells

Allow me to introduce you to Adult Stem Cells.

STEM CELLS 101 pic

STEM CELLS 101 – short


  • SOURCE/DERIVED FROM – comes from blood, umbilical cords, bone marrow, placenta fat tissue, muscle, nasal neurological, breast milk, menstruation, dental pulp, and many more
  • PURPOSE IN BODY – they are the body’s natural healing cells
  • OBSTACLES+SIDE EFFECTS – ~zero problems (virtually zero side effects)
  • TREATMENT HISTORY – used in bone marrow transplants to treat cancer for 40 years
  • TREATMENT HISTORY – can currently treat 130+ diseases safely and effectively (CP, MS, Autism, Diabetes, CHF, PAD, etc)

To see if your condition can be treated with Adult stem cells, please fill out this form: http://bit.ly/PATIENTQUESTIONNAIRE

cbs logoCBS has been against Adult Stem Cells for years.  They repeatedly referred to the doctors and scientists involved in adult stem cell treatments as quacks, crooks, con-men and scam artists.  They refer to adult stem cell treatments as snake oil despite a record of safety and efficacy going back to 2002! At the same time, CBS has been promoting the ‘huge potential of embryonic stem cell treatments.’  I take no pleasure in the irony that the CBS “eye” has been completely blind to the benefits of Adult stem cells for years while the rest of the world touted their benefits and the rest of the world’s patients recovered from terminal, chronic and incurable illnesses while American patients had zero options for recovery.

For a history of stem cell treatments of heart disease going back to 2002 – https://repairstemcell.wordpress.com/heart-disease-treatment/

All of this has now changed.  CBS has done a 180 degree flip and are now advocates for the benefits of Adult stem cells!

CBS VIDEO on Adult Stem Cell Success with Heart Disease

CBS ARTICLE on Adult Stem Cell Success with Heart Disease

Clinical Trial in The Lancet CBS Based Their Reporting On

Irony number 2 is that CBS uses words like “breakthrough” and “first ever.”


Do you know there are 443 clinical trials at clinicaltrials.gov with the keywords “stem cell” and “cardiac?”  There is not a single one which is a completed Embryonic stem cell trial.  Point of fact, there is not a single completed Embryonic stem cell trial for any disease anywhere. There are over 2,000 completed Adult stem cell trials.


Do you know there are 5,170 peer reviewed published studies with the keywords “adult stem cell” and “cardiac?”



With the death of Embryonic stem cell treatments and the RE-discovery of Adult stem cell treatments, don’t you owe it to yourself to see if Adult stem cells can help you?

To see if your condition can be treated with Adult stem cells,

please fill out this form: http://bit.ly/PATIENTQUESTIONNAIRE


In ALL ARTICLES on October 27, 2011 at 8:57 pm

Tolerance to Composite Tissue Allografts is Dependent on the Administration of Hematopoietic Stem Cells but not Long-Term Engraftment

David Mathes1,2, Jeff Chang1,2, Scott Graves2, Billana Huang2, Tiffany Miwongtum2, Rainer Storb2

1Department of Surgery, Division of Plastic and Reconstructive Surgery, University of Washington; 2Transplantation Biology Research Center, Fred Hutchinson Cancer Research Center; Seattle, Washington, USA

Introduction: Composite tissue allografts (CTA) are a clinical reality.  However, the survival of these transplants is dependent on immunosuppression. This experiment sought to develop a large animal model for the simultaneous transplantation of hematopoietic stem cells (HSC) and CTA using our mixed chimerism protocol and to examine the role of the HSC infusion.

Methods: 4 transplants were performed across a DLA matched, minor mismatch barrier. All dogs received 200 cGy of radiation and a CTA transplant with injection of HSC. 3 dogs underwent the protocol except without an HSC infusion. All dogs received 35 days of post-grafting immunosuppression and were followed for donor cell chimerism and underwent biopsies. Tolerant animals underwent a donor and third-party skin graft. Finally, they were followed for levels of FoxP3 and GranzymeB in the transplanted muscle and skin.

Results: All of the experimental animals demonstrated long-term tolerance to the CTA (497, 467, 465, and 400 days). 3 of 4 dogs had long-term detectable donor chimerism. One dog lost its chimerism at 10 weeks post-transplant but remained tolerant to the CTA. The expression of CD3+ FoxP3 was stable in the tolerant transplanted muscle and skin.  It was also noted to be elevated in the draining lymph node. The three dogs transplanted without an HSC infusion rejected their transplants at 45 days after the cessation of post-grafting immunosuppression. All of the tolerant dogs accepted the donor skin graft and promptly rejected the third-party graft.

Conclusion: The simultaneous transplant of HSC and CTA leads to tolerance. This tolerance induction appears to be dependent on the administration of HSC but not its long-term engraftment. This finding suggests that modifications to the protocol that promote initial engraftment but not long-term presence of donor cells will be key to the development of a protocol that can used on complete mismatched transplants.



In VICTORIES & SUCCESS STORIES on October 27, 2011 at 8:01 pm

SILENCE OF THE LAMBS MEETS STEM CELLS and future transplant recipients win big!!

https://repairstemcell.files.wordpress.com/2011/10/anthony_hopkins_hannibal_lecter.jpg?w=147Remember in Silence of the Lambs, at the end of the movie, when Hannibal Lecter cuts off the guards face and then wears it out to escape?  It turns out, if he had some stem cells to go with that face transplant, he could have just kept on wearing it. 

Surgical researchers did exactly that on four dogs and all 4 of the dogs tolerated the face transplants for over one year without immunosuppressive drugs after the first month.  – David


Surgeons Develop Simultaneous Tissue and Stem Cell Transplant Technique

Released: 10/18/2011 11:00 AM EDT
Embargo expired: 10/27/2011 2:15 PM EDT
Source: American College of Surgeons (ACS)

New method shows promise in eliminating the need for long-term antirejection drugs, particularly for hand and face transplants

Newswise — SAN FRANCISCO: Surgical researchers at the University of Washington, Seattle, have pioneered a method using stem cells that may one day eliminate the need for antirejection drugs in transplants. Primary investigator David Mathes, MD, FACS, and his research fellow Jeff Chang, MD, MS, presented their findings today at the 2011 Clinical Congress of the American College Surgeons. Two groups of patients who might one day benefit from this early research breakthrough are hand and face transplant recipients. To date, survival of these transplants has depended on administering high-dose drugs to patients that suppress the immune system like those used in major organ transplants. However, these drugs are expensive and have a multitude of side effects, the researchers explained.

The surgeons performed simultaneous transplants of vascularized composite allografts—transplanted tissue with the blood vessels intact—and stem cells in four dogs followed by a short course of immune-suppressing drugs. All four dogs accepted the grafts without complications. After about a month, the researchers discontinued all immune system suppressing drugs. One dog rejected its stem cell transplant 10 weeks after the operation, but continued to tolerate the composite allograft for over one year without immunosuppression.

The other three dogs tolerated both stem cells and composite allografts for over one year. The investigators also performed vascularized composite allograft transplants without the stem cells on three other dogs. All three rejected the transplants after immune-suppressing drugs were stopped.

“If this technique works and proceeds into a clinical model, we would be able to transplant patients with either face or hands or even solid organs without the need for long-term immunosuppression drugs,” according to Dr. Chang. Physicians prescribe these drugs to people who have undergone hand and face transplants because organ transplant recipients, such as those receiving a liver or kidney, must take high-dose drugs to suppress the immune system and stave off organ rejection. Innovators of the hand and face transplants have followed this protocol to similarly prevent tissue rejection.

However, the side effects of these drugs have been widely reported. Kidney transplant recipients, for example, have a heightened risk of developing diabetes and hypertension. These drugs also raise the likelihood of infections and malignancy in all transplant recipients, Dr. Chang explained. Moveover, the American Society of Transplant Surgeons has estimated that immune-suppressing drugs can cost up to $25,000 a year per person.

While solid organ transplants are considered life-prolonging procedures in which the benefits outweigh the drug side effects, Dr. Chang noted that hand and face transplants do not fit this category. “Face and hand transplants are not life-saving procedures, so not subjecting these patients to the risks of immunosuppression would certainly be beneficial to them,” Dr. Chang said.

Although this research is still in an early phase, an important new finding the University of Washington study unveiled is the role that stem cells play in making the body tolerant of transplanted tissue, Dr. Chang said. “It’s interesting that you can modulate the immune system in such a way that you can transplant other cells into the recipient and the recipient becomes tolerant of them,” he said.

The study involved vascularized composite allograft transplants matched to the recipient’s tissue type. The next step is to attempt transplants in what Dr. Chang called a “mismatched” setting—where the donor and recipient tissue types do not necessarily match. “If we can get this to work in a mismatched setting it would be more clinically relevant,” Dr. Chang said.

Dr. Mathes and his collaborators at the Fred Hutchinson Cancer Research Center are attempting to develop this experimental model into a more clinical model for humans. The use of a canine model for this research is significant because large animals more closely resemble human anatomy and physiology with regard to composite allograft transplants, whereas “trying this method in small animals, such as laboratory mice, would be more difficult to translate into humans,” Dr. Chang explained.

Although the researchers embarked on developing this technique with hand and face transplants in mind, simultaneous mismatched tissue and stem cell transplantation may also hold promise for solid organ transplants. “If we extend this technique into solid organ transplantation, it would assist with a major problem; whether or not you need a complete match,” Dr. Chang said. “The other problem is supply and demand. If we can break the immunological barriers in such a way that would let us transplant a mismatched kidney, it would help greatly with the shortage of organs.”

David Mathes, MD, FACS, is the primary investigator for this project. Jeff Chang, MD, MS, is his research fellow. Both collaborated with Rainer Storb, MD, at the Fred Hutchinson Cancer Research Center in Seattle.

Surgeons Develop Simultaneous Tissue and Stem Cell Transplant Technique.

For those of you interested in the https://i2.wp.com/www.imodownload.com/imageupload/hcb_01.jpgbehind this, go here:


CATCH UP ALREADY!! Heart Stem Cells Move Closer to Human Treatments

In VICTORIES & SUCCESS STORIES on February 25, 2010 at 3:29 pm

It’s nice they are recognizing the benefits of adult stem cells finally.  But they are still slow to catch up to the UNDENIABLE SCIENTIFIC PROOF.

Heart Stem Cells Move Closer to Human Treatments

‘Patch’ for damaged heart is just one of several promising developments
By Amanda Gardner, HealthDay Reporter

WEDNESDAY, Feb. 24 (HealthDay News) — Researchers are moving ahead — although sometimes ploddingly — toward the goal of using stem cell therapies to rescue people with cardiovascular disease, the leading killer of men and women in the United States.

Although much of the gains thus far have been in basic science, stem cells do seem close to actually being able to help actual humans.

“We have seen consistent but modest effects of stem cells in improving heart function and reverse remodeling of heart,” said Dr. Gordon Tomaselli, a spokesman for the American Heart Association and an associate professor of medicine at the Johns Hopkins University School of Medicine in Baltimore.

“I think there’s great hope,” added Dr. Darwin J. Prockop, director of the Texas A&M Health Science Center College of Medicine Institute for Regenerative Medicine at Scott & White in Temple.

Several studies presented last November at the annual scientific sessions of the American Heart Association in Orlando serve as examples.

In one study, out of Germany, 35 patients who received bone-marrow stem cell transplantation during coronary artery bypass surgery achieved “excellent long-term safety and survival.”

Ten patients who received similar transplantations after repair of mitral valves also fared well, with improvements in the heart’s pumping capacity.

Slovenian investigators had similar success, with improvements seen in patients with advanced heart failure who received bone-marrow derived stem cells.

There were also advances in gene therapy reported, with Singaporean researchers using nanotechnology to deliver genetically modified cells to help heal heart attack damage in rabbits.

The stem cell promise hinges on the ability to produce unlimited supplies of human cardiac cells, experts say.

Kevin Eggan, chief scientific officer for the New York Stem Cell Foundation and associate professor of stem cell and regenerative biology at Harvard University, noted two breakthrough treatments that would require steady production of stem cells.

One is a future “patch” made out of these cells to fix a damaged heart after a heart attack. Researchers also hope to fashion blood vessels out of stem cells for use in bypass surgery and other procedures.

“People are making very substantial progress in being able to make those various vascular cells you would need,” Eggan said. “Transplanting those is something that will come from all of this.”

More immediately, perhaps, is the use of stem cells to screen heart drugs, sort of like test-driving the drugs in preclinical trials, Eggan said.//

“You can do this in a couple of different ways,” Eggan said. Researchers could determine in a laboratory dish if a drug actually works on heart cells, he said. The other method would involve manufacturing heart cells for a variety of people to find out which cells the drugs work on.

“One of the tricky things about drug trials is they often don’t work on all people equally well,” Eggan explained. “You have to study a whole lot of people to be able to see any sort of effects. This would screen out people that the drug doesn’t work on. It would enable personalized medicine.”

One innovation that is close to market, Eggan said, is a method for identifying and eliminating toxic drugs before they go into clinical trials.

A system is in the works that would involve testing drugs on heart muscle cells in a lab dish.

“This could save enormous time and money in clinical trials,” Eggan said.

Gene therapy has not advanced as far, he added, but predicts that it will combine with stem cell therapies in the future.

“The one good thing that really has come out is that nobody has been harmed by [the stem cell] therapies,” Prockop pointed out.

More information


Related Encyclopedia
•    Alzheimer’s Disease
•    Aneurysms
•    Angina Pectoris
•    Angiogram

Related Healthscout Videos
Icy Treatments Revive the Dead
No Pain Heart Health
Taking Steps After a Stroke
Opening Doors to a Sickle Cell Cure

Related Animations
•    Alzheimer’s Disease Video Animation
•    Angioplasty
•    Coronary Bypass Surgery
•    Erectile Dysfunction

Related Drug Information
•    Accupril
•    Actonel
•    Altace
•    Avapro

Related News Articles
•    New Heart CT Scans Deliver Far Less Radiation: Study
•    Health Tip: Warning Signs That You May Have Chronic Fatigue Syndrome
•    More Expensive Hospital Care May Not Mean Better
•    Hospital Stays May Spur Brain Decline in Seniors

Johns Hopkins stem cell research site is launched

In ALL ARTICLES on October 5, 2009 at 1:51 pm

Web site on Johns Hopkins stem cell research is launched

September 28, 2009 – By Gazette Contributor

In conjunction with last week’s 2009 World Stem Cell Summit, co-hosted by Johns Hopkins and held in Baltimore, Johns Hopkins Medicine launched an interactive Web site on which its researchers and clinicians collectively describe their explorations into stem cell biology and engineering.

The multimedia production, which went live Sept. 21 at http://www.hopkinsmedicine.org/stem_cell_research, emphasizes applications of stem cell technologies in regenerative medicine and underscores the collaborative effort that is fundamental to translational research.

The site includes everything from a narrated timeline of stem cell research to a video feature of a Johns Hopkins patient, physician and bench scientist who are linked by stem cell research as it relates to Parkinson’s disease. Johns Hopkins experts also weigh in on state-of-the-art issues of ethics and safety as they apply to stem cells.

via Web site on Johns Hopkins stem cell research is launched : The Gazette.

%d bloggers like this: